Overview
Giammarco Collemi practices practicing medicine in Turin, Italy.
Their clinical expertise encompasses Solitary Fibrous Tumor, Extramammary Paget Disease, and Vulvar Cancer.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Giammarco Collemi
Is Giammarco Collemi a top-rated expert for Solitary Fibrous Tumor?
MediFind is an objective health platform that identifies experts based on real-world data. Giammarco Collemi is classified as an Experienced expert for Solitary Fibrous Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Giammarco Collemi participate in research or clinical trials?
Yes. Giammarco Collemi has published 8 articles and abstracts on conditions like Solitary Fibrous Tumor. You can view a list of Giammarco Collemi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Extramammary Paget DiseaseCollemi isExperienced. Learn about Extramammary Paget Disease.
- Solitary Fibrous TumorCollemi isExperienced. Learn about Solitary Fibrous Tumor.
- Vulvar CancerCollemi isExperienced. Learn about Vulvar Cancer.